These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3444192)

  • 21. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunity in chronic bronchitis patients with significant residual changes after prior pulmonary tuberculosis].
    Ditiatkov AE; Antonova OIu; Shevelev VI; Rvacheva AV; Kaznacheeva EI; Beĭlina VB; Tkachev GA; Zykov KA
    Probl Tuberk Bolezn Legk; 2008; (3):14-7. PubMed ID: 18453053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Natural killer cell immunodeficiency and herpesvirus infection in tuberculosis].
    Karalian MA; Stepanian SM; Ulumian AK; Karapetian ET
    Probl Tuberk Bolezn Legk; 2007; (3):25-8. PubMed ID: 17500223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological and nonspecific reactivity in patients with infiltrative pulmonary tuberculosis associated with chronic nonspecific lung diseases].
    Morozova TI; Khudzik LB; Rebrov AP
    Probl Tuberk; 1995; (4):14-7. PubMed ID: 7567859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of serum immunoglobulins in pulmonary tuberculosis patients.
    Jha VK; Bajpai BK; Gupta RM
    Indian J Chest Dis; 1974 Oct; 16(4):361-7. PubMed ID: 4469261
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro tuberculin reaction and cellular and humoral immune response in patients with pulmonary tuberculosis].
    de Araujo AC; Takeda AK; Herrero CB; de Freitas IW; Nakandakare IK; Guedes EA; Brólio R
    Rev Saude Publica; 1983 Apr; 17(2):94-111. PubMed ID: 6648301
    [No Abstract]   [Full Text] [Related]  

  • 29. [Natural killer cells in middle-aged and elderly tuberculosis patients].
    Adambekov DA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):18-21. PubMed ID: 7778367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open versus laparoscopic surgery: a comparison of natural antitumoral cellular immunity in a small animal model.
    Sandoval BA; Robinson AV; Sulaiman TT; Shenk RR; Stellato TA
    Am Surg; 1996 Aug; 62(8):625-30; discussion 630-1. PubMed ID: 8712558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis.
    Ratcliffe LT; Mackenzie CR; Lukey PT; Ress SR
    Scand J Immunol Suppl; 1992; 11():167-70. PubMed ID: 1514034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Level of immunoglobulins in tuberculosis].
    Rowińska E
    Gruzlica; 1971 Oct; 39(10):965-75. PubMed ID: 5160218
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complex medico-social characteristics of newly diagnosed patients with pulmonary tuberculosis].
    Zinov'ev IP; Mileeva LM; Zaĭtseva GA; Aganina EG
    Probl Tuberk; 1995; (3):11-2. PubMed ID: 7617621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comprehensive study of patient immunological reactivity in combined pulmonary tuberculosis and diabetes mellitus].
    Adambekov DA; Al'dzhambaev ShIu; Pokotilo DI
    Probl Tuberk; 1980 Jun; (6):25-7. PubMed ID: 7393905
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE USE OF "REAMBERIN" AS BIOLOGICAL RESPONSE MODIFIER TO INCREASE THE NATURAL KILLER CELLS' CYTOTOXICITY IN PATIENTS WITH LUNG TUBERCULOSIS].
    Kholamov AI; Mirzomogomedova VG; Chernoshey DA; Lizunov ES
    Eksp Klin Farmakol; 2015; 78(8):22-4. PubMed ID: 26591578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Roncoleukin immunomodulation in pulmonary tuberculosis].
    Knoring BE; El'kin AV; Smirnov MN; Sakharova IIa; Basek TS
    Probl Tuberk; 1999; (5):26-9. PubMed ID: 10565213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of biochemical and immunological indices in the diagnosis of the activity of limited forms of pulmonary tuberculosis].
    Kostina ZI; Pokhodzeĭ IV; Kotenko TV; Gerasimova EV; Obrosova TI
    Probl Tuberk; 1986; (4):18-23. PubMed ID: 3714697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculosis in the course of Hodgkin's disease].
    Leménager J; Tanguy A; Bérnard Y
    Cah Med; 1972 Apr; 13(5):357-62. PubMed ID: 5055112
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of HLA-DR2 on perforin-positive cells in pulmonary tuberculosis.
    Rajeswari DN; Selvaraj P; Raghavan S; Jawahar MS; Narayanan PR
    Int J Immunogenet; 2007 Oct; 34(5):379-84. PubMed ID: 17845310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological studies of pulmonary infection with atypical mycobacteria I. Enumeration of lymphocyte subsets in the peripheral blood].
    Harada Y; Harada S; Takamoto M; Kitahara Y; Ishibashi T; Shinoda A
    Kekkaku; 1988 Aug; 63(8):555-61. PubMed ID: 3184586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.